Image Credits: FAMILY IMAGE PROVIDED FOR STAR TRIBUNE When two-year old, Kenize was bitten by a puppy in a freak accident, she easily could have lost the top 1/3 of her ear. Yet, it was Hyperbaric Oxygen Therapy that saved the day; and her ear. The Riemenschneiders...
It is estimated that around 5,000,000 Americans suffer from chronic, non-healing wounds as a result of injuries and diseases such as ulcers, diabetes, and circulatory problems. Even though our bodies are made to heal the average wound, many wounds exist that are...
Courtesy Image of David Rachels receiving HBOTDavid Rachels was critically injured in mid-March when he was riding his scooter to work and a Dodge Ram pickup truck ran a red light. Rachels was thankfully wearing a full-face motorcycle helmet, but he did sustain...
The purpose of this pilot study is to assess the efficacy of Microlyte Ag wound dressing when
used in complex skin wounds. Microlyte Ag is a class-II medical device cleared by the FDA for
prescription and over the counter use in humans. Primary clinical end point of study is
percentage change in wound size from initiation of Microlyte Ag treatment through 90 days or
until wound closure. Patient population comprises patients referred to Mission’s Wound
Healing and Hyperbaric Center for management of their wounds. Targeted enrollment is 100
subjects distributed into 4 study cohorts corresponding to the type of wound treated: venous
stasis ulcer (20 patients); diabetic foot ulcer [DFU] (20 patients); pressure ulcer (20
patients); wounds of various other etiologies (40 patients).